Changes in Clinical Control of COPD Patients Measured by the Clinical COPD Questionnaire During Therapy With Spiolto®Respimat® in Routine Clinical Practice
Changes in Clinical Control of COPD Patients Measured by the Clinical COPD Questionnaire During Therapy With Spiolto®Respimat® in Routine Clinical Practice
Open-label observational study which includes COPD patients that are receiving treatment with Spiolto® Respimat® for approximately 6 weeks, which is the average time between two medical consultations.
Inclusion Criteria:
Exclusion Criteria:
CeskyTesinKonakov, 735 62, Czechia
Dobřís, 26301, Czechia
Hustopece U Brna, 693 01, Czechia
Mlada Boreslav, 29301, Czechia
Orlová - Lutyně, 735 14, Czechia
Miskolc, 3529, Hungary
Jerusalem East, 9103102, Israel
Tel-Hashomer / Ramat Gan, 5262000, Israel
Zrifin, 70300, Israel
Bochnia, 32-700, Poland
Poznan, 60-313, Poland
Jud Constanta, 38079525, Romania
Jud. Cluj, Mun. Cluj-Napoca, 400414, Romania
Jud. Cluj, Mun. Cluj-Napoca, 400426, Romania
Jud. Giurgiu , Mun. Giurgiu, 80121, Romania
Mun. Târgu Jiu, 210164, Romania
Sat Ariniș, 437010, Romania
Sat Visan, Jud Iasi, 700285, Romania
Tg.Lăpuș, 435600, Romania
Checkov 2, 142302, Russia
Chelyabinsk, 454106, Russia
Kemerovo, 650993, Russia
Krasnoyarsk, 661123, Russia
Moscow, 105077, Russia
Moscow, 117449, Russia
Moscow, 125222, Russia
Moscow, 127540, Russia
Nizhny Novgorod, 603005, Russia
Novovsibirsk, 630099, Russia
Perm, 614038, Russia
Saint Petersburg, 197022, Russia
Simferopol, 295024, Russia
Simferopol, 950000, Russia
Volgograd, 400120, Russia
Voronezh, 394018, Russia
Yaroslavl, 150062, Russia
Škofja Vas, 3211, Slovenia
Utznach, 8730, Switzerland
Kyiv, 3038, Ukraine